- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04840056
Prediksjon av gastrisk kreft i intestinal metaplasi og atrofisk gastritt (GIMA)
Prediksjon av gastrisk kreft i intestinal metaplasi og atrofisk gastritt - Anvendelse av kunstig intelligens i histologi og kliniske data
The primary objectives of this study are:
- To identify clinical or histological factors associated with gastric cancer development in patients with IM and AG
- To establish a machine learning algorithm for prediction of future gastric cancer risks and individual risk stratification in patient with IM and AG
Studieoversikt
Status
Detaljert beskrivelse
This is a two-part retrospective study including a clinical data part and a pathology part. A training cohort will be developed from approximately 70% of included cases. It will be followed by a validation cohort with the remaining cases.
Clinical data will be collected retrospectively using the Clinical Data Analysis and Reporting System (CDARS) and Clinical management System (CMS). A cluster-wide cohort (New Territories East Cluster, NTEC) consisting of patients with history of histologically-proven gastric IM and AG will be identified and included for subsequent analysis. The data collection period for the retrospective data will be 2000-2020.
Histology slides will be retrieved retrospectively when available (within NTEC). Whole slide imaging technique will be utilized for the development of training and validation cohorts with machine learning algorithms in the pathology part.
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: Felix Sia
- Telefonnummer: +85226370428
- E-post: felix.sia@cuhk.edu.hk
Studer Kontakt Backup
- Navn: Thomas Lam
- Telefonnummer: +85226370428
- E-post: thomas.lam@cuhk.edu.hk
Studiesteder
-
-
New Territories
-
Shatin, New Territories, Hong Kong
- Rekruttering
- Prince of Wales Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Clinical data will be collected retrospectively using the Clinical Data Analysis and Reporting System (CDARS) and Clinical management System (CMS). A cluster-wide cohort (New Territories East Cluster, NTEC) consisting of patients with history of histologically-proven gastric IM and AG will be identified and included for subsequent analysis. The data collection period for the retrospective data will be 2000-2020.
Histology slides will be retrieved retrospectively when available (within NTEC). Whole slide imaging technique will be utilized for the development of training and validation cohorts with machine learning algorithms in the pathology part.
Beskrivelse
Inclusion Criteria:
- Adults >= 18 years of age
- Histologically proven atrophic gastritis or intestinal metaplasia (at antrum and/or body and/or angular of stomach)
Exclusion Criteria:
- none
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: COHORT
- Tidsperspektiver: RETROSPECTIVE
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
Intestinal Metaplasia
patient with history of histologically proven gastric intestinal metaplasia |
|
Atrophic gastritis
patient with history of histologically proven atrophic gastritis |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Gastric cancer and gastric dysplasia
Tidsramme: 20 years
|
The primary endpoint is the incidence of gastric cancer (intestinal-type) and gastric dysplasia (low grade and high grade dysplasia). |
20 years
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Overall accuracy of machine learning model
Tidsramme: 20 years
|
Overall accuracy of machine learning models will be evaluated |
20 years
|
|
Sensitivity of machine learning model
Tidsramme: 20 years
|
Sensitivity of machine learning model will be evaluated |
20 years
|
|
Specificity of machine learning model
Tidsramme: 20 years
|
Specificity of machine learning model will be evaluated |
20 years
|
|
Positive predictive value of machine learning model
Tidsramme: 20 years
|
Positive predictive value of machine learning model will be evaluated |
20 years
|
|
Negative predictive value of machine learning model
Tidsramme: 20 years
|
Negative predictive value of machine learning model will be evaluated |
20 years
|
|
Area under the receiver operating characteristic curve of machine learning model
Tidsramme: 20 years
|
Area under the receiver operating characteristic curve of machine learning model will be evaluated |
20 years
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2021.082
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
There is no plan to share IPD with other researchers
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .